Urologix, Inc.
Urologix, Inc. (ULGX) Stock Competitors & Peer Comparison
See (ULGX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ULGX | $0.00 | -0.00% | 2.2K | -0.01 | -$0.01 | N/A |
| SMMNY | $28.04 | +1.08% | 125.9B | 25.99 | $1.08 | +1.05% |
| SEMHF | $56.90 | +5.32% | 63.8B | 26.34 | $2.16 | +1.74% |
| RYLPF | $26.01 | +9.07% | 24.7B | 86.70 | $0.30 | +3.65% |
| SONVF | $299.78 | +5.28% | 17.9B | 26.58 | $11.28 | +1.74% |
| SONVY | $58.85 | -1.13% | 17.6B | 26.06 | $2.26 | +1.07% |
| CHEOY | $102.47 | -0.67% | 13.4B | 55.69 | $1.84 | +1.36% |
| SNNUF | $14.94 | +1.29% | 13.1B | 31.79 | $0.47 | +2.51% |
| CHEOF | $193.04 | +0.00% | 12.6B | 52.31 | $3.69 | +1.44% |
| WILYY | $20.19 | +0.00% | 9B | 19.41 | $1.04 | N/A |
Stock Comparison
ULGX vs SMMNY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, SMMNY has a market cap of 125.9B. Regarding current trading prices, ULGX is priced at $0.00, while SMMNY trades at $28.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas SMMNY's P/E ratio is 25.99. In terms of profitability, ULGX's ROE is +2.32%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, ULGX is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check SMMNY's competition here
ULGX vs SEMHF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, SEMHF has a market cap of 63.8B. Regarding current trading prices, ULGX is priced at $0.00, while SEMHF trades at $56.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas SEMHF's P/E ratio is 26.34. In terms of profitability, ULGX's ROE is +2.32%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, ULGX is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check SEMHF's competition here
ULGX vs RYLPF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, RYLPF has a market cap of 24.7B. Regarding current trading prices, ULGX is priced at $0.00, while RYLPF trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas RYLPF's P/E ratio is 86.70. In terms of profitability, ULGX's ROE is +2.32%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, ULGX and RYLPF have similar daily volatility (0.00).Check RYLPF's competition here
ULGX vs SONVF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, SONVF has a market cap of 17.9B. Regarding current trading prices, ULGX is priced at $0.00, while SONVF trades at $299.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas SONVF's P/E ratio is 26.58. In terms of profitability, ULGX's ROE is +2.32%, compared to SONVF's ROE of +0.22%. Regarding short-term risk, ULGX and SONVF have similar daily volatility (0.00).Check SONVF's competition here
ULGX vs SONVY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, SONVY has a market cap of 17.6B. Regarding current trading prices, ULGX is priced at $0.00, while SONVY trades at $58.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas SONVY's P/E ratio is 26.06. In terms of profitability, ULGX's ROE is +2.32%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, ULGX is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check SONVY's competition here
ULGX vs CHEOY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CHEOY has a market cap of 13.4B. Regarding current trading prices, ULGX is priced at $0.00, while CHEOY trades at $102.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CHEOY's P/E ratio is 55.69. In terms of profitability, ULGX's ROE is +2.32%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, ULGX is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check CHEOY's competition here
ULGX vs SNNUF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, SNNUF has a market cap of 13.1B. Regarding current trading prices, ULGX is priced at $0.00, while SNNUF trades at $14.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas SNNUF's P/E ratio is 31.79. In terms of profitability, ULGX's ROE is +2.32%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, ULGX and SNNUF have similar daily volatility (0.00).Check SNNUF's competition here
ULGX vs CHEOF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CHEOF has a market cap of 12.6B. Regarding current trading prices, ULGX is priced at $0.00, while CHEOF trades at $193.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CHEOF's P/E ratio is 52.31. In terms of profitability, ULGX's ROE is +2.32%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, ULGX and CHEOF have similar daily volatility (0.00).Check CHEOF's competition here
ULGX vs WILYY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, WILYY has a market cap of 9B. Regarding current trading prices, ULGX is priced at $0.00, while WILYY trades at $20.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas WILYY's P/E ratio is 19.41. In terms of profitability, ULGX's ROE is +2.32%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, ULGX is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check WILYY's competition here
ULGX vs WILLF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, WILLF has a market cap of 9B. Regarding current trading prices, ULGX is priced at $0.00, while WILLF trades at $43.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas WILLF's P/E ratio is 21.15. In terms of profitability, ULGX's ROE is +2.32%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, ULGX and WILLF have similar daily volatility (0.00).Check WILLF's competition here
ULGX vs GNGBY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, GNGBY has a market cap of 5.6B. Regarding current trading prices, ULGX is priced at $0.00, while GNGBY trades at $20.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas GNGBY's P/E ratio is 37.41. In terms of profitability, ULGX's ROE is +2.32%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, ULGX and GNGBY have similar daily volatility (0.00).Check GNGBY's competition here
ULGX vs GNGBF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, GNGBF has a market cap of 5.3B. Regarding current trading prices, ULGX is priced at $0.00, while GNGBF trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas GNGBF's P/E ratio is 36.84. In terms of profitability, ULGX's ROE is +2.32%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, ULGX and GNGBF have similar daily volatility (0.00).Check GNGBF's competition here
ULGX vs AMBBY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, AMBBY has a market cap of 4.1B. Regarding current trading prices, ULGX is priced at $0.00, while AMBBY trades at $15.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas AMBBY's P/E ratio is 70.05. In terms of profitability, ULGX's ROE is +2.32%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, ULGX is less volatile compared to AMBBY. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check AMBBY's competition here
ULGX vs NHNKY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, NHNKY has a market cap of 4.1B. Regarding current trading prices, ULGX is priced at $0.00, while NHNKY trades at $12.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas NHNKY's P/E ratio is 22.02. In terms of profitability, ULGX's ROE is +2.32%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, ULGX is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check NHNKY's competition here
ULGX vs AMBFF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, AMBFF has a market cap of 4B. Regarding current trading prices, ULGX is priced at $0.00, while AMBFF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas AMBFF's P/E ratio is 69.09. In terms of profitability, ULGX's ROE is +2.32%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, ULGX is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check AMBFF's competition here
ULGX vs NHNKF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, ULGX is priced at $0.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, ULGX's ROE is +2.32%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, ULGX is less volatile compared to NHNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check NHNKF's competition here
ULGX vs GNNDY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, GNNDY has a market cap of 2.3B. Regarding current trading prices, ULGX is priced at $0.00, while GNNDY trades at $48.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas GNNDY's P/E ratio is 18.76. In terms of profitability, ULGX's ROE is +2.32%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, ULGX and GNNDY have similar daily volatility (0.00).Check GNNDY's competition here
ULGX vs GGNDF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, ULGX is priced at $0.00, while GGNDF trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas GGNDF's P/E ratio is 16.53. In terms of profitability, ULGX's ROE is +2.32%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, ULGX is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check GGNDF's competition here
ULGX vs MCRPF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, MCRPF has a market cap of 2B. Regarding current trading prices, ULGX is priced at $0.00, while MCRPF trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas MCRPF's P/E ratio is -9.23. In terms of profitability, ULGX's ROE is +2.32%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, ULGX and MCRPF have similar daily volatility (0.00).Check MCRPF's competition here
ULGX vs STSEY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, ULGX is priced at $0.00, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas STSEY's P/E ratio is 39.41. In terms of profitability, ULGX's ROE is +2.32%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, ULGX and STSEY have similar daily volatility (0.00).Check STSEY's competition here
ULGX vs VTRLY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, ULGX is priced at $0.00, while VTRLY trades at $14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas VTRLY's P/E ratio is 42.80. In terms of profitability, ULGX's ROE is +2.32%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, ULGX and VTRLY have similar daily volatility (0.00).Check VTRLY's competition here
ULGX vs OSSFF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, ULGX is priced at $0.00, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, ULGX's ROE is +2.32%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, ULGX is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check OSSFF's competition here
ULGX vs DWRKF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, ULGX is priced at $0.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, ULGX's ROE is +2.32%, compared to DWRKF's ROE of N/A. Regarding short-term risk, ULGX and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here
ULGX vs OSSUY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, ULGX is priced at $0.00, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, ULGX's ROE is +2.32%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, ULGX and OSSUY have similar daily volatility (0.00).Check OSSUY's competition here
ULGX vs MEDGF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, ULGX is priced at $0.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, ULGX's ROE is +2.32%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, ULGX and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here
ULGX vs DRWKF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, ULGX is priced at $0.00, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas DRWKF's P/E ratio is 9.40. In terms of profitability, ULGX's ROE is +2.32%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, ULGX and DRWKF have similar daily volatility (0.00).Check DRWKF's competition here
ULGX vs DGWPF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, ULGX is priced at $0.00, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas DGWPF's P/E ratio is 7.96. In terms of profitability, ULGX's ROE is +2.32%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, ULGX is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check DGWPF's competition here
ULGX vs ELEAF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, ELEAF has a market cap of 1.1B. Regarding current trading prices, ULGX is priced at $0.00, while ELEAF trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas ELEAF's P/E ratio is 15.51. In terms of profitability, ULGX's ROE is +2.32%, compared to ELEAF's ROE of +0.15%. Regarding short-term risk, ULGX and ELEAF have similar daily volatility (0.00).Check ELEAF's competition here
ULGX vs LFTSF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, ULGX is priced at $0.00, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, ULGX's ROE is +2.32%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, ULGX and LFTSF have similar daily volatility (0.00).Check LFTSF's competition here
ULGX vs MDRSF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, MDRSF has a market cap of 828.1M. Regarding current trading prices, ULGX is priced at $0.00, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, ULGX's ROE is +2.32%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, ULGX is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check MDRSF's competition here
ULGX vs XVIPF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, XVIPF has a market cap of 693M. Regarding current trading prices, ULGX is priced at $0.00, while XVIPF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas XVIPF's P/E ratio is 61.11. In terms of profitability, ULGX's ROE is +2.32%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, ULGX is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check XVIPF's competition here
ULGX vs CALZF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CALZF has a market cap of 590.7M. Regarding current trading prices, ULGX is priced at $0.00, while CALZF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CALZF's P/E ratio is 85.50. In terms of profitability, ULGX's ROE is +2.32%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, ULGX and CALZF have similar daily volatility (0.00).Check CALZF's competition here
ULGX vs AVMR Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, ULGX is priced at $0.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas AVMR's P/E ratio is -18.34. In terms of profitability, ULGX's ROE is +2.32%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, ULGX and AVMR have similar daily volatility (0.00).Check AVMR's competition here
ULGX vs CLVSF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, ULGX is priced at $0.00, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, ULGX's ROE is +2.32%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, ULGX and CLVSF have similar daily volatility (0.00).Check CLVSF's competition here
ULGX vs IOBCF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, IOBCF has a market cap of 407.5M. Regarding current trading prices, ULGX is priced at $0.00, while IOBCF trades at $13.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas IOBCF's P/E ratio is 38.64. In terms of profitability, ULGX's ROE is +2.32%, compared to IOBCF's ROE of +0.09%. Regarding short-term risk, ULGX and IOBCF have similar daily volatility (0.00).Check IOBCF's competition here
ULGX vs CSSPF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CSSPF has a market cap of 384M. Regarding current trading prices, ULGX is priced at $0.00, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, ULGX's ROE is +2.32%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, ULGX is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check CSSPF's competition here
ULGX vs HYBT Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, ULGX is priced at $0.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas HYBT's P/E ratio is N/A. In terms of profitability, ULGX's ROE is +2.32%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, ULGX and HYBT have similar daily volatility (0.00).Check HYBT's competition here
ULGX vs EAPIF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, EAPIF has a market cap of 347.6M. Regarding current trading prices, ULGX is priced at $0.00, while EAPIF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas EAPIF's P/E ratio is -2.27. In terms of profitability, ULGX's ROE is +2.32%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, ULGX is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check EAPIF's competition here
ULGX vs CYBQY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CYBQY has a market cap of 280.3M. Regarding current trading prices, ULGX is priced at $0.00, while CYBQY trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CYBQY's P/E ratio is -62.00. In terms of profitability, ULGX's ROE is +2.32%, compared to CYBQY's ROE of -0.01%. Regarding short-term risk, ULGX and CYBQY have similar daily volatility (0.00).Check CYBQY's competition here
ULGX vs BRSYF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, BRSYF has a market cap of 256.2M. Regarding current trading prices, ULGX is priced at $0.00, while BRSYF trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas BRSYF's P/E ratio is 61.64. In terms of profitability, ULGX's ROE is +2.32%, compared to BRSYF's ROE of +0.07%. Regarding short-term risk, ULGX is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check BRSYF's competition here
ULGX vs CLLKF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CLLKF has a market cap of 245.2M. Regarding current trading prices, ULGX is priced at $0.00, while CLLKF trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CLLKF's P/E ratio is -7.89. In terms of profitability, ULGX's ROE is +2.32%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, ULGX is less volatile compared to CLLKF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check CLLKF's competition here
ULGX vs HTLZF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, ULGX is priced at $0.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, ULGX's ROE is +2.32%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, ULGX and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here
ULGX vs BCCOY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, BCCOY has a market cap of 221M. Regarding current trading prices, ULGX is priced at $0.00, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, ULGX's ROE is +2.32%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, ULGX is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check BCCOY's competition here
ULGX vs IMPZY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, IMPZY has a market cap of 199.9M. Regarding current trading prices, ULGX is priced at $0.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, ULGX's ROE is +2.32%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, ULGX and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here
ULGX vs PXMBF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, PXMBF has a market cap of 187.5M. Regarding current trading prices, ULGX is priced at $0.00, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, ULGX's ROE is +2.32%, compared to PXMBF's ROE of +0.12%. Regarding short-term risk, ULGX and PXMBF have similar daily volatility (0.00).Check PXMBF's competition here
ULGX vs DTXMF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, ULGX is priced at $0.00, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, ULGX's ROE is +2.32%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, ULGX is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check DTXMF's competition here
ULGX vs CYBQF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CYBQF has a market cap of 160.1M. Regarding current trading prices, ULGX is priced at $0.00, while CYBQF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CYBQF's P/E ratio is -60.00. In terms of profitability, ULGX's ROE is +2.32%, compared to CYBQF's ROE of -0.01%. Regarding short-term risk, ULGX and CYBQF have similar daily volatility (0.00).Check CYBQF's competition here
ULGX vs EKDHF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, EKDHF has a market cap of 157.2M. Regarding current trading prices, ULGX is priced at $0.00, while EKDHF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas EKDHF's P/E ratio is 17.50. In terms of profitability, ULGX's ROE is +2.32%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, ULGX is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check EKDHF's competition here
ULGX vs DMTRF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, DMTRF has a market cap of 156.9M. Regarding current trading prices, ULGX is priced at $0.00, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, ULGX's ROE is +2.32%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, ULGX is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check DMTRF's competition here
ULGX vs AVHHL Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, AVHHL has a market cap of 153.6M. Regarding current trading prices, ULGX is priced at $0.00, while AVHHL trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas AVHHL's P/E ratio is -3.07. In terms of profitability, ULGX's ROE is +2.32%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, ULGX is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check AVHHL's competition here
ULGX vs AMEUF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, ULGX is priced at $0.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, ULGX's ROE is +2.32%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, ULGX is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check AMEUF's competition here
ULGX vs SNZZF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, SNZZF has a market cap of 114.8M. Regarding current trading prices, ULGX is priced at $0.00, while SNZZF trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas SNZZF's P/E ratio is -7.30. In terms of profitability, ULGX's ROE is +2.32%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, ULGX and SNZZF have similar daily volatility (0.00).Check SNZZF's competition here
ULGX vs VMTHF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, ULGX is priced at $0.00, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, ULGX's ROE is +2.32%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, ULGX is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check VMTHF's competition here
ULGX vs JMDMF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, ULGX is priced at $0.00, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, ULGX's ROE is +2.32%, compared to JMDMF's ROE of N/A. Regarding short-term risk, ULGX is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check JMDMF's competition here
ULGX vs IPDQF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, IPDQF has a market cap of 104.2M. Regarding current trading prices, ULGX is priced at $0.00, while IPDQF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas IPDQF's P/E ratio is -5.14. In terms of profitability, ULGX's ROE is +2.32%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, ULGX is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check IPDQF's competition here
ULGX vs RSHUF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, ULGX is priced at $0.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, ULGX's ROE is +2.32%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, ULGX is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check RSHUF's competition here
ULGX vs SOMNF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, SOMNF has a market cap of 90.8M. Regarding current trading prices, ULGX is priced at $0.00, while SOMNF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas SOMNF's P/E ratio is -14.00. In terms of profitability, ULGX's ROE is +2.32%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, ULGX is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check SOMNF's competition here
ULGX vs CKMTF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, ULGX is priced at $0.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, ULGX's ROE is +2.32%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, ULGX and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here
ULGX vs FDMDF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, FDMDF has a market cap of 75.7M. Regarding current trading prices, ULGX is priced at $0.00, while FDMDF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas FDMDF's P/E ratio is -2.32. In terms of profitability, ULGX's ROE is +2.32%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, ULGX is less volatile compared to FDMDF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check FDMDF's competition here
ULGX vs RDGL Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, RDGL has a market cap of 58.9M. Regarding current trading prices, ULGX is priced at $0.00, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas RDGL's P/E ratio is -13.00. In terms of profitability, ULGX's ROE is +2.32%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, ULGX is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check RDGL's competition here
ULGX vs BLOZF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, BLOZF has a market cap of 52.4M. Regarding current trading prices, ULGX is priced at $0.00, while BLOZF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas BLOZF's P/E ratio is -22.77. In terms of profitability, ULGX's ROE is +2.32%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, ULGX is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check BLOZF's competition here
ULGX vs BRNHF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, BRNHF has a market cap of 42.2M. Regarding current trading prices, ULGX is priced at $0.00, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, ULGX's ROE is +2.32%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, ULGX and BRNHF have similar daily volatility (0.00).Check BRNHF's competition here
ULGX vs NVYTF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, NVYTF has a market cap of 38.9M. Regarding current trading prices, ULGX is priced at $0.00, while NVYTF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas NVYTF's P/E ratio is -0.74. In terms of profitability, ULGX's ROE is +2.32%, compared to NVYTF's ROE of +0.00%. Regarding short-term risk, ULGX is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check NVYTF's competition here
ULGX vs TLTFF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, TLTFF has a market cap of 36.9M. Regarding current trading prices, ULGX is priced at $0.00, while TLTFF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas TLTFF's P/E ratio is -14.70. In terms of profitability, ULGX's ROE is +2.32%, compared to TLTFF's ROE of -2.57%. Regarding short-term risk, ULGX is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check TLTFF's competition here
ULGX vs ELXMF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, ULGX is priced at $0.00, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, ULGX's ROE is +2.32%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, ULGX and ELXMF have similar daily volatility (0.00).Check ELXMF's competition here
ULGX vs MKEAF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, ULGX is priced at $0.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, ULGX's ROE is +2.32%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, ULGX and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here
ULGX vs EMITF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, EMITF has a market cap of 24.6M. Regarding current trading prices, ULGX is priced at $0.00, while EMITF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas EMITF's P/E ratio is -12.33. In terms of profitability, ULGX's ROE is +2.32%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, ULGX is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check EMITF's competition here
ULGX vs KBBTF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, ULGX is priced at $0.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, ULGX's ROE is +2.32%, compared to KBBTF's ROE of N/A. Regarding short-term risk, ULGX and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here
ULGX vs POSC Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, POSC has a market cap of 23.1M. Regarding current trading prices, ULGX is priced at $0.00, while POSC trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas POSC's P/E ratio is 0.40. In terms of profitability, ULGX's ROE is +2.32%, compared to POSC's ROE of +9.25%. Regarding short-term risk, ULGX is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check POSC's competition here
ULGX vs ASAPF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, ASAPF has a market cap of 19.5M. Regarding current trading prices, ULGX is priced at $0.00, while ASAPF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas ASAPF's P/E ratio is -25.00. In terms of profitability, ULGX's ROE is +2.32%, compared to ASAPF's ROE of -0.23%. Regarding short-term risk, ULGX is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check ASAPF's competition here
ULGX vs MDXHF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, MDXHF has a market cap of 18.8M. Regarding current trading prices, ULGX is priced at $0.00, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, ULGX's ROE is +2.32%, compared to MDXHF's ROE of +0.49%. Regarding short-term risk, ULGX is less volatile compared to MDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check MDXHF's competition here
ULGX vs GTHP Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, GTHP has a market cap of 18.5M. Regarding current trading prices, ULGX is priced at $0.00, while GTHP trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas GTHP's P/E ratio is -4.70. In terms of profitability, ULGX's ROE is +2.32%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, ULGX is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check GTHP's competition here
ULGX vs PYNKF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, PYNKF has a market cap of 18.1M. Regarding current trading prices, ULGX is priced at $0.00, while PYNKF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas PYNKF's P/E ratio is -0.87. In terms of profitability, ULGX's ROE is +2.32%, compared to PYNKF's ROE of -1.58%. Regarding short-term risk, ULGX is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check PYNKF's competition here
ULGX vs DIZTF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, ULGX is priced at $0.00, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, ULGX's ROE is +2.32%, compared to DIZTF's ROE of -2.22%. Regarding short-term risk, ULGX is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check DIZTF's competition here
ULGX vs VPTDF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, VPTDF has a market cap of 17.8M. Regarding current trading prices, ULGX is priced at $0.00, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas VPTDF's P/E ratio is -5.34. In terms of profitability, ULGX's ROE is +2.32%, compared to VPTDF's ROE of +1.70%. Regarding short-term risk, ULGX is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check VPTDF's competition here
ULGX vs TMDIF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, ULGX is priced at $0.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, ULGX's ROE is +2.32%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, ULGX is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check TMDIF's competition here
ULGX vs PLLWF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, ULGX is priced at $0.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, ULGX's ROE is +2.32%, compared to PLLWF's ROE of -0.61%. Regarding short-term risk, ULGX is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check PLLWF's competition here
ULGX vs IMEXF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, IMEXF has a market cap of 11.9M. Regarding current trading prices, ULGX is priced at $0.00, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas IMEXF's P/E ratio is N/A. In terms of profitability, ULGX's ROE is +2.32%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, ULGX and IMEXF have similar daily volatility (0.00).Check IMEXF's competition here
ULGX vs ATBPF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, ULGX is priced at $0.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, ULGX's ROE is +2.32%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, ULGX is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check ATBPF's competition here
ULGX vs LXXGF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, ULGX is priced at $0.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, ULGX's ROE is +2.32%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, ULGX and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here
ULGX vs RMSL Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, RMSL has a market cap of 11.1M. Regarding current trading prices, ULGX is priced at $0.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas RMSL's P/E ratio is 0.73. In terms of profitability, ULGX's ROE is +2.32%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, ULGX is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check RMSL's competition here
ULGX vs NGMDF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, NGMDF has a market cap of 8.5M. Regarding current trading prices, ULGX is priced at $0.00, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas NGMDF's P/E ratio is -3.74. In terms of profitability, ULGX's ROE is +2.32%, compared to NGMDF's ROE of +0.36%. Regarding short-term risk, ULGX and NGMDF have similar daily volatility (0.00).Check NGMDF's competition here
ULGX vs FZMD Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, FZMD has a market cap of 7.4M. Regarding current trading prices, ULGX is priced at $0.00, while FZMD trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas FZMD's P/E ratio is 2.00. In terms of profitability, ULGX's ROE is +2.32%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, ULGX is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check FZMD's competition here
ULGX vs ALRTF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, ALRTF has a market cap of 6.4M. Regarding current trading prices, ULGX is priced at $0.00, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas ALRTF's P/E ratio is -0.33. In terms of profitability, ULGX's ROE is +2.32%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, ULGX and ALRTF have similar daily volatility (0.00).Check ALRTF's competition here
ULGX vs QLIS Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, ULGX is priced at $0.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas QLIS's P/E ratio is 2.22. In terms of profitability, ULGX's ROE is +2.32%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, ULGX and QLIS have similar daily volatility (0.00).Check QLIS's competition here
ULGX vs RHNMF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, ULGX is priced at $0.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, ULGX's ROE is +2.32%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, ULGX is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check RHNMF's competition here
ULGX vs NUMD Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, NUMD has a market cap of 4.2M. Regarding current trading prices, ULGX is priced at $0.00, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas NUMD's P/E ratio is 5.00. In terms of profitability, ULGX's ROE is +2.32%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, ULGX is less volatile compared to NUMD. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check NUMD's competition here
ULGX vs LBLTF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, ULGX is priced at $0.00, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, ULGX's ROE is +2.32%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, ULGX and LBLTF have similar daily volatility (0.00).Check LBLTF's competition here
ULGX vs ADMT Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, ADMT has a market cap of 4M. Regarding current trading prices, ULGX is priced at $0.00, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas ADMT's P/E ratio is -5.87. In terms of profitability, ULGX's ROE is +2.32%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, ULGX and ADMT have similar daily volatility (0.00).Check ADMT's competition here
ULGX vs TBRIF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, TBRIF has a market cap of 3.8M. Regarding current trading prices, ULGX is priced at $0.00, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas TBRIF's P/E ratio is -0.99. In terms of profitability, ULGX's ROE is +2.32%, compared to TBRIF's ROE of -2.28%. Regarding short-term risk, ULGX and TBRIF have similar daily volatility (0.00).Check TBRIF's competition here
ULGX vs VANIW Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, ULGX is priced at $0.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas VANIW's P/E ratio is N/A. In terms of profitability, ULGX's ROE is +2.32%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, ULGX is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check VANIW's competition here
ULGX vs VYCO Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, VYCO has a market cap of 3.3M. Regarding current trading prices, ULGX is priced at $0.00, while VYCO trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas VYCO's P/E ratio is -10.00. In terms of profitability, ULGX's ROE is +2.32%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, ULGX is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check VYCO's competition here
ULGX vs PMEDF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, PMEDF has a market cap of 3.3M. Regarding current trading prices, ULGX is priced at $0.00, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas PMEDF's P/E ratio is -1.69. In terms of profitability, ULGX's ROE is +2.32%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, ULGX is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check PMEDF's competition here
ULGX vs ESMC Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, ESMC has a market cap of 3M. Regarding current trading prices, ULGX is priced at $0.00, while ESMC trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas ESMC's P/E ratio is 8.00. In terms of profitability, ULGX's ROE is +2.32%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, ULGX and ESMC have similar daily volatility (0.00).Check ESMC's competition here
ULGX vs BIEL Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, BIEL has a market cap of 2.9M. Regarding current trading prices, ULGX is priced at $0.00, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas BIEL's P/E ratio is N/A. In terms of profitability, ULGX's ROE is +2.32%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, ULGX is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check BIEL's competition here
ULGX vs ODYY Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, ODYY has a market cap of 2.2M. Regarding current trading prices, ULGX is priced at $0.00, while ODYY trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas ODYY's P/E ratio is -0.15. In terms of profitability, ULGX's ROE is +2.32%, compared to ODYY's ROE of +2.30%. Regarding short-term risk, ULGX and ODYY have similar daily volatility (0.00).Check ODYY's competition here
ULGX vs USAQ Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, USAQ has a market cap of 2M. Regarding current trading prices, ULGX is priced at $0.00, while USAQ trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas USAQ's P/E ratio is -4.50. In terms of profitability, ULGX's ROE is +2.32%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, ULGX and USAQ have similar daily volatility (0.00).Check USAQ's competition here
ULGX vs IRME Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, IRME has a market cap of 1.8M. Regarding current trading prices, ULGX is priced at $0.00, while IRME trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas IRME's P/E ratio is -0.83. In terms of profitability, ULGX's ROE is +2.32%, compared to IRME's ROE of +11.77%. Regarding short-term risk, ULGX is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check IRME's competition here
ULGX vs CRRVF Comparison July 2025
ULGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ULGX stands at 2.2K. In comparison, CRRVF has a market cap of 1.5M. Regarding current trading prices, ULGX is priced at $0.00, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ULGX currently has a P/E ratio of -0.01, whereas CRRVF's P/E ratio is N/A. In terms of profitability, ULGX's ROE is +2.32%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, ULGX is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for ULGX.Check CRRVF's competition here